Methylation profile of selected TSGs in non-cancerous thyroid tissue adjacent to primary PTC

Monika Migdalska-Sęk; Dorota Pastuszak-Lewandoska; Karolina Czarnecka; Ewa Nawrot; Daria Domańska; Jan Brzeziński; Marek Dedecjus; Ewa Brzeziańska

doi:10.5114/wo.2011.24312

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/2011
vol. 15

Send email

Copy url:

abstract:

Original paper

Methylation profile of selected TSGs in non-cancerous thyroid tissue adjacent to primary PTC

Monika Migdalska-Sęk

,

Dorota Pastuszak-Lewandoska

,

Karolina Czarnecka

,

Ewa Nawrot

,

Daria Domańska

,

Jan Brzeziński

,

Marek Dedecjus

,

Ewa Brzeziańska

Wspolczesna Onkol 2011; 15 (4): 191–197

DOI: https://doi.org/10.5114/wo.2011.24312

Online publish date: 2011/09/09

View full text Get citation

PlumX metrics:

Aim of the study: The aim of the study was to analyse the methylation profile of the eight tumour suppressor genes (TSGs) ARHI, CDH1, KCNQ1, MEST, p16INK4A, RASSF1A, SLC5A8 and VHLin noncancerous thyroid tissue adjacent to papillary thyroid carcinoma (PTC) and to assess whether it parallels the methylation level of the studied TSGs in the primary tumour.

Material and methods: Thyroid tissue samples were obtained from patients with PTC from the centre of the primary lesion and the adjacent noncancerous tissue, macroscopically unchanged (n = 11). Genomic DNA was modified with sodium bisulfite and methylation-specific polymerase chain reactions (MSPs) were performed. For each studied TSG methylated and unmethylated MSP primers were designed. Quality and quantity of MSP products were assessed in automated electrophoresis.

Results: Qualitative analysis revealed the presence of methylated and nonmethylated alleles both in PTC and normal thyroid tissue for all genes, except one (KCNQ1). The highest methylation frequency was observed for ARHI, CDH1, p16INK4A, MEST and RASSF1A. Quantitative assessment confirmed a very high methylation level (MI values) for ARHI, CDH1 and RASSF1A. Methylation levels of the studied TSGs were only slightly higher in the PTC group.

Conclusions: Alterations of TSG methylation levels in thyroid tissue may be considered as an early molecular event, specific not only for cancerous lesions. Epigenetic modifications of these genes may be of functional importance for thyroid carcinogenesis. On the other hand, it may be explained by the concept of field cancerization.

keywords:

Methylation profile of selected TSGs in non-cancerous thyroid tissue adjacent to primary PTC

Monika Migdalska-Sęk , Dorota Pastuszak-Lewandoska , Karolina Czarnecka , Ewa Nawrot , Daria Domańska , Jan Brzeziński , Marek Dedecjus , Ewa Brzeziańska

promoter hypermethylation, tumour suppressor genes, carcinogenesis, papillary thyroid carcinoma

Monika Migdalska-Sęk

,

Dorota Pastuszak-Lewandoska

,

Karolina Czarnecka

,

Ewa Nawrot

,

Daria Domańska

,

Jan Brzeziński

,

Marek Dedecjus

,

Ewa Brzeziańska